文献速递神经肿瘤

术后早期IGF-1下降预测肢端肥大症手术缓解

Early Postoperative Decline in Insulin-Like Growth Factor 1 (IGF-1) Predicts Surgical Remission of Acromegaly.
PubMed 文献 · World Neurosurg · 2025-11-03

该单中心回顾性队列纳入1999年至2025年接受手术的生长激素分泌型垂体腺瘤患者49例,比较术后早期校正IGF-1及其较术前的下降幅度对术后3个月激素缓解的预测价值。结果显示,缓解组术后早期校正IGF-1更低、围手术期下降幅度更大,两者ROC曲线下面积分别为0.841和0.783。

要点

  • 术后数天内IGF-1下降幅度可预测术后3个月肢端肥大症缓解。
  • 缓解组术后早期校正IGF-1为1.13±0.44倍正常上限,未缓解组为1.89±0.53倍(P<0.01)。
  • 建议出院前检测IGF-1,用于患者咨询和早期随访强度安排。

核心结论

  • 垂体手术后数天内IGF-1下降程度可预测术后3个月肢端肥大症缓解。
  • 作者主张出院前测定IGF-1,以指导住院期间患者咨询和早期随访强度。

研究设计与样本

  • 回顾性单中心队列研究,纳入1999年1月1日至2025年1月1日手术治疗的生长激素分泌型垂体腺瘤患者。
  • 共49例,平均年龄47.6±12.5岁,女性29例(59%)。
  • 比较术后早期校正IGF-1(按正常上限校正)及较术前下降幅度对术后3个月激素缓解(IGF-1正常)的预测价值。

主要发现

  • 术前校正IGF-1均值为2.50倍正常上限(标准差0.88),术后早期(平均术后4天)校正IGF-1为1.43±0.6倍正常上限(P<0.001)。
  • 3个月缓解者术后早期校正IGF-1低于未缓解者(1.13±0.44 vs. 1.89±0.53,P<0.01)。
  • 围手术期IGF-1下降幅度在缓解者中更大(49.7±21.8 vs. 22.2±30.6,P<0.01)。
  • 术后早期校正IGF-1预测3个月缓解的ROC曲线下面积为0.841;围手术期IGF-1下降幅度的ROC曲线下面积为0.783。

临床怎么用

  • 术后数天内检测IGF-1及其较术前下降幅度,可辅助预判3个月激素缓解。
  • 出院前测定IGF-1有助于住院期间患者咨询并指导早期随访强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the utility of perioperative decline in insulin-like growth factor 1 (IGF-1) in predicting 3-month remission in patients undergoing surgery for growth hormone-secreting pituitary adenomas. METHODS: This was a retrospective, single-center cohort study of patients with surgically managed growth hormone-secreting pituitary adenomas from January 1, 1999, to January 1, 2025. We compared the utility of early postoperative adjusted IGF-1 (adjusted to upper limit of normal) and early postoperative adjusted IGF-1 reduction compared with preoperative levels to predict hormonal remission (normal IGF-1) at 3 months' postoperatively. Other clinical/radiologic factors associated with 3-month remission also were examined. RESULTS: We identified 49 patients with mean age 47.6 ± 12.5 years (standard deviation 12.5 years); 29 were female (59%). Mean values were 2.50-fold the upper limit of normal (standard deviation 0.88) for preoperative adjusted IGF-1 and 1.43 ± 0.6 the upper limit of normal for early postoperative adjusted IGF-1 (P < 0.001) measured at a mean of 4 days postoperatively. Early postoperative adjusted IGF-1 was lower in those who achieved 3-month remission versus those who did not (1.13 ± 0.44 vs. 1.89 ± 0.53, P < 0.01), and perioperative IGF-1 reduction was considerably greater (49.7 ± 21.8 vs. 22.2 ± 30.6, P < 0.01). Receiver operating curve of early postoperative adjusted IGF-1 in predicting 3-month remission demonstrated an area under the curve of 0.841. Receiver operating curve of perioperative IGF-1 reduction demonstrated an area under the curve of 0.783. CONCLUSIONS: The degree of IGF-1 decline within days of pituitary surgery predicts 3-month acromegaly remission. Our findings argue for IGF-1 measurement before discharge to inform patient counseling during the surgical admission and guide intensity of early follow-up.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ovenden C, Mignone E, Chapman I, et al. Early Postoperative Decline in Insulin-Like Growth Factor 1 (IGF-1) Predicts Surgical Remission of Acromegaly. World Neurosurg. 2025. PMID: 41192502. doi:10.1016/j.wneu.2025.124611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。